menu

Assessing the Role of Immunomodulators in IBD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD

close
Crohn’s & Colitis Congress 2021: Assessing the Role of Immunomodulators in IBD
Restart
Resume
Read full article
Copy the following code snippet below to display this program on your web site:
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • In Partnership with

  • Overview

    With current treatment approaches in mind, how do immunomodulators fit into the therapeutic landscape for inflammatory bowel disorders, or IBD? In preparation for the 2021 Crohn’s & Colitis Congress, Dr. Charles Turck speaks with Dr. Maria Oliva-Hemker from Johns Hopkins University School of Medicine about her presentation at the event. 

Facebook Comments

Recommended
Details
Presenters
Comments
  • In Partnership with

  • Overview

    With current treatment approaches in mind, how do immunomodulators fit into the therapeutic landscape for inflammatory bowel disorders, or IBD? In preparation for the 2021 Crohn’s & Colitis Congress, Dr. Charles Turck speaks with Dr. Maria Oliva-Hemker from Johns Hopkins University School of Medicine about her presentation at the event. 

Facebook Comments

Programs 5/13/21